T-cell subset analysis of peripheral T-cell lymphomas by paraffin section immunohistology and correlation of CD4/CD8 results with flow cytometry

American Journal of Clinical Pathology

Volumn 109, Issue 5, 1998, Pages 610-617

  Macon, William R ^a   Salhany, Kevin E ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

CD4; CD8; Flow cytometry; Paraffin immunoperoxidase; Peripheral T cell lymphomas; TCR ; TIA 1; F1

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; IMMUNOPHENOTYPING; LYMPHOMA; PRIORITY JOURNAL; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE SUBPOPULATION;

EID: 0031895650     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/109.5.610     Document Type: Article

References (41)

1. Waldron JA, Leech JH, Glick AD, et al. Malignant lymphoma of peripheral T-lymphocyte origin: immunologic, pathologic, and clinical features in six patients. Cancer. 1977; 40:1604-1607.
2. Greer JP, York JC, Cousar JB, et al. Peripheral T-cell lymphoma: a clinicopathologic study of 42 cases. J Clin Oncol. 1984;2:788-797.
3. Suchi T, Lennert K, Tu L-Y, et al. Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification. J Clin Pathol. 1987;40:995-1015.
4. Armitage JO, Greer JP, Levine AM, et al. Peripheral T-cell lymphoma. Cancer. 1989;63:158-163.
5. Pinkus GS, O'Hara CJ, Said JW. Peripheral/post-thymic T-cell lymphomas: a spectrum of disease: clinical, pathologic, and immunologic features of 78 cases. Cancer. 1990;65:971-998.
6. Winberg CD. Peripheral T-cell lymphoma: morphologic and immunologic observations. Am J Clin Pathol. 1993;99:426-435.
7. Jones DB, Wright DH, Paul F, et al. Phenotypic heterogeneity displayed by T-non Hodgkin's lymphoma (T-NHL) cells dispersed from diagnostic lymph node biopsies. Hematol Oncol. 1986;4:219-226.
8. Borowitz MJ, Reichert TA, Brynes RK, et al. The phenotypic diversity of peripheral T-cell lymphomas: the Southeastern Cancer Study Group experience. Hum Pathol. 1986; 17:567-574.
9. Weiss LM, Crabtree GS, Rouse RV, et al. Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas. Am J Pathol 1985;118:316-324.
10. Weis JW, Winter MW, Phyliky RL, et al. Peripheral T-cell lymphomas: histologic, immunohistologic, and clinical characterization. Mayo Clin Proc. 1986;61:411-426.
11. Macon WR, Casey TT, Kinney MC, et al. Leu-22 (L60): A more sensitive marker than UCHL1 for peripheral T-cell lymphomas, particularly large-cell types. Am J Clin Pathol. 1991;95:696-701.
12. Cabeçadas JM, Isaacson PG. Phenotyping of T-cell lymphomas in paraffin sections: which antibodies? Histopathology. 1991;19:419-424.
13. Kurtin PJ, Roche PC. Immunoperoxidase staining of non-Hodgkin's lymphomas for T-cell lineage associated antigens in paraffin sections: comparison of the performance characteristics of four commercially available antibody preparations. Am J Surg Pathol. 1993;17:898-904.
14. Chadburn A, Knowles DM. Paraffin-resistant antigens detectable by antibodies L26 and CD3 predict the B- or T-cell lineage of 95% of diffuse aggressive non-Hodgkin's lymphomas. Am J Clin Pathol. 1994;102:284-291.
15. + T lymphocytes. J Immunol. 1990;144:574-582.
16. Krajewski AS, Myskow MW, Salter DM, et al. Diagnosis of T-cell lymphoma using beta F1, anti-T-cell receptor beta chain antibody. Histopathology. 1989;15:239-247.
17. Said JW, Shintaku IP, Parekh K, et al. Specific phenotyping of T-cell proliferations in formalin-fixed paraffin-embedded tissues: use of antibodies to the T-cell receptor βF1. Am J Clin Pathol. 1990;93:382-386.
18. Gaulard P, Bourquelot P, Kanavaros P, et al. Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas: identification of a subset of γ/δ T-cell lymphomas. Am J Pathol. 1990;137:617-628.
19. Harris NL, Jaffe ES, Stein H, et al. A Revised European-American Classification of Lymphoid Neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
20. Macon WR, Williams ME, Greer JP, et al. Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood. 1996;87:1474-1483.
21. Ip SI, Rittershaus CW, Healy KW, et al. Rapid enumeration of T lymphocytes by a flow-cytometric immunofluorescence method. Clin Chem. 1985;28:1905-1909.
22. Hsu S-M, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol. 1981;75:816-821.
23. Picker LJ, Weiss LM, Medeiros LJ, et al. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol. 1987;128:181-201.
24. Hastrup N, Ralfkiaer E, Pallesen G. Aberrant phenotypes in peripheral T cell lymphomas. J Clin Pathol. 1989;42:398-402.
25. Ng CS, Chan JKC, Hui PK, et al. Application of a T cell receptor antibody βF1 for immunophenotypic analysis of malignant lymphomas. Am J Pathol. 1988;132:365-371.
26. Chan WC, Borowitz MJ, Hammami A, et al. T-cell receptor antibodies in the immunohistochemical studies of normal and malignant lymphoid cells. Cancer. 1988;62:2118-2124.
27. Merz H, Malisius R, Mannweiler S, et al. ImmunoMax: a maximized immunohistochemical method for the retrieval and enhancement of hidden antigens. Lab Invest. 1995;73:149-156.
28. Casey TT, Posey DH, McCurley TL. OKT4 epitope deficiency in significant proportions of the black population: a cause for underestimation of helper/suppressor lymphocyte ratios. Arch Pathol Lab Med. 1986;110:702-704.
29. Angadi C. Lack of Leu-3a epitope on T-helper (CD4) lymphocytes. J Clin Lab Anal. 1990;4:193-195.
30. Kisielow P, Von Boehmer H. Development and selection of T cells: facts and puzzles. In: Dixon FJ, ed. Advances in Immunology. San Diego, Calif: Academic Press; 1995;58:87-209.
31. Krenacs L, Wellmann A, Sorbara L, et al. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Blood. 1997;89:980-989.
32. Felgar RE, Macon WR, Kinney MC, et al. TIA-1 expression in lymphoid neoplasms: identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. Am J Pathol. 1997;150:1893-1900.
33. + anaplastic large cell lymphomas (ALCL) support a cytolytic lymphocyte (CTL) phenotype and correlate with P80 expression, T cell phenotype and young patient age. Mod Pathol. 1997;10:125A. Abstract.
34. Salhany KE, Macon WR, Choi JK, et al. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic immunophenotypic, and genotypic analysis of αβ and γδ subtypes. Am J Surg Pathol. In press.
35. Kumar S, Krenacs L, Raffeld M, et al. Subcutaneous panniculitis-like T-cell lymphoma is a tumor of cytotoxic T lymphocytes. Mod Pathol. 1997;10:129A. Abstract.
36. Salhany KE, Feldman M, Kahn MJ, et al. Hepatosplenic γδ T cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation. Hum Pathol. 1997;28:674-685.
37. Cooke CV, Krenacs L, Stetlar-Stevenson M, et al. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic γδ T-cell origin. Blood. 1996;88:4265-4274.
38. Greer JP, Kinney MC, Collins RD, et al. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol. 1991;9:539-547.
39. Chott A, Dragosics B, Radaszkiewicz T. Peripheral T-cell lymphomas of the intestine. Am J Pathol. 1992;141:1361-1371.
40. Gonzalez CL, Medeiros LJ, Braziel RM, et al. T-cell lymphoma involving subcutaneous tissue: a clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol. 1991;15:17-27.
41. Nakamura S, Suchi T. A clinicopathologic study of node-based, low-grade, peripheral T-cell lymphoma: angioimmunoblastic lymphoma, T-zone lymphoma, and lymphoepithelial lymphoma. Cancer. 1991;67:2565-2578.